• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

Recent Advances in the Application of 2-amino-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carboxylic acid (CAS: 1239060-03-7) in Chemical Biology and Drug Discovery

The compound 2-amino-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carboxylic acid (CAS: 1239060-03-7) has emerged as a promising building block in chemical biology and drug discovery due to its unique structural features and versatile reactivity. This boronic acid derivative combines a pyridine core with a tetramethyl dioxaborolane moiety, making it an attractive candidate for the development of novel pharmaceuticals and chemical probes. Recent studies have highlighted its potential in targeted drug delivery, enzyme inhibition, and as a key intermediate in the synthesis of complex bioactive molecules.

One of the most significant applications of this compound lies in its role as a boronic acid-based warhead for protease inhibitors. Researchers have demonstrated its efficacy in inhibiting serine proteases, a class of enzymes implicated in numerous pathological conditions, including cancer, inflammation, and infectious diseases. The boronic acid group forms reversible covalent bonds with the active site serine residue, leading to potent and selective enzyme inhibition. Recent structural-activity relationship (SAR) studies have optimized the substitution pattern on the pyridine ring to enhance binding affinity and pharmacokinetic properties.

In the field of cancer therapeutics, 2-amino-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carboxylic acid has shown promise as a precursor for the development of boron neutron capture therapy (BNCT) agents. The high boron content and favorable biodistribution properties of derivatives based on this scaffold make them suitable for this emerging radiation therapy approach. Recent preclinical studies have reported improved tumor selectivity and reduced systemic toxicity compared to traditional BNCT agents.

The compound's utility extends to chemical biology applications, where it serves as a versatile handle for bioconjugation and probe development. The amino and carboxylic acid functional groups allow for straightforward derivatization, while the boronic ester moiety enables selective reactions with diols and other nucleophiles. Recent work has demonstrated its successful incorporation into activity-based protein profiling (ABPP) probes, enabling the study of enzyme function in complex biological systems.

From a synthetic chemistry perspective, recent advances have focused on improving the scalability and efficiency of producing 2-amino-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carboxylic acid. Novel catalytic systems and optimized protection-deprotection strategies have been developed to address previous challenges in large-scale synthesis. These improvements have significantly enhanced the compound's accessibility for both academic and industrial research applications.

Looking forward, the unique properties of 2-amino-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carboxylic acid position it as a valuable tool for addressing current challenges in drug discovery, particularly in the development of covalent inhibitors and targeted therapies. Ongoing research is exploring its potential in addressing antibiotic resistance, neurodegenerative diseases, and immune modulation. The compound's versatility and the growing understanding of its structure-activity relationships suggest it will continue to be an important focus of chemical biology research in the coming years.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)